Endothelium-mediated dilations contribute to the polarity of the arterial wall in vasomotion induced by alpha 2-adrenergic agonists.
We tested whether or not an endothelium-mediated dilation is involved in the response of intact arteries to alpha-adrenergic stimulation, by separately applying agonists to the luminal or adventitial side of the arterial wall. Cumulative dose-response curves of the alpha 1-agonists l-phenylephrine or cirazoline applied luminally in rat tail arteries and in side branches of canine femoral arteries were identical to those obtained by adventitial application in the intact arteries, and were not modified by removal of the endothelium (eliminating acetylcholine-induced dilations). Constrictions induced by the alpha 2-agonists UK-14,304 or azepexole applied luminally were significantly lower than those induced by adventitial application, and were augmented significantly by removal of the endothelium. Half-maximally precontracted arteries were dilated by addition of alpha 2-agonists to the luminal perfusate; these dilations were abolished by removal of the endothelium. It is concluded that the functional polarity of the vascular wall of these arteries in response to alpha 2-agonists results from the release of a dilatory signal from the endothelial cells, counteracting the direct contractile activation of the adjacent smooth muscle cells by the agonists.
H
H
Matsuda
E
E
Kuon
J
J
Holtz
R
R
Busse
D015121:6-Ketoprostaglandin F1 alpha / Q000378:metabolism; D000109:Acetylcholine / Q000494:pharmacology; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001158:Arteries / Q000502:physiology*; D000068438:Brimonidine Tartrate; D004305:Dose-Response Relationship, Drug; D004727:Endothelium / Q000502:physiology; D005260:Female; D005263:Femoral Artery / Q000187:drug effects; D007093:Imidazoles / Q000494:pharmacology; D008297:Male; D010656:Phenylephrine / Q000494:pharmacology; D011810:Quinoxalines / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D014664:Vasodilation / Q000187:drug effects*; D015016:Yohimbine / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000959:Antihypertensive Agents; D007093:Imidazoles; D011810:Quinoxalines; D010656:Phenylephrine; D015016:Yohimbine; D000068438:Brimonidine Tartrate; D015121:6-Ketoprostaglandin F1 alpha; D000109:Acetylcholine; C014282:cirazoline